SRRK - Scholar Rock Holding Corporation
| Previous Close | 10.47 |
| Open | 10.45 |
| Bid | 8.30 x 800 |
| Ask | 11.25 x 900 |
| Day's Range | 10.12 - 10.45 |
| 52 Week Range | 6.95 - 26.95 |
| Volume | 108,673 |
| Avg. Volume | 76,180 |
| Market Cap | 305M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Scholar Rock Holding Corporation (SRRK) Reports Q3 Loss, Misses Revenue Estimates
Scholar Rock Holding Corporation (SRRK) delivered earnings and revenue surprises of -77.42% and -62.48%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- GuruFocus.com
Analysts See 2 Falling Knives Bouncing Back
They have a low financial burden Continue reading...
- Insider Monkey
Hedge Funds Have Never Been This Bullish On Scholar Rock Holding Corporation (SRRK)
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons. Nevertheless, the data show elite investors' consensus picks have done well on average over the long-term. The top 20 stocks among hedge funds beat the S&P […]
- Zacks
Will Scholar Rock Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor Scholar Rock Holding.
- Simply Wall St.
Is There An Opportunity With Scholar Rock Holding Corporation's (NASDAQ:SRRK) 21% Undervaluation?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Scholar Rock Holding...
- Simply Wall St.
Did Changing Sentiment Drive Scholar Rock Holding's (NASDAQ:SRRK) Share Price Down By 19%?
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active...
- Motley Fool
Why Carnival, Steelcase, and Scholar Rock Holding Slumped Today
Find out why these stocks missed the rally.
- Motley Fool
Why Scholar Rock Is Sinking Today
The good news? The cause of the drop should be a temporary issue.
- Insider Monkey
Is Scholar Rock Holding Corporation (SRRK) A Good Stock To Buy?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]
- Zacks
Sarepta's NDA for DMD Drug Golodirsen Gets Priority Review
FDA accepts Sarepta's (SRPT) regulatory application seeking approval for DMD therapy, golodirsen, and grants priority review. A decision is expected in August 2019.
- Simply Wall St.
Read This Before Selling Scholar Rock Holding Corporation (NASDAQ:SRRK) Shares
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be remiss not to mention that insider sales have Read More...
- Investopedia
Gilead Stock Breaks Out to Channel Resistance
Gilead Sciences shares posted gains on Thursday morning after Bistrol-Myers' acquisition of Celgene sent shares across the sector higher.
- Motley Fool
Why Cabot Oil & Gas, Uxin, and Scholar Rock Holding Slumped Today
Several stocks simply lost momentum from past successes.
- Zacks
Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal
It was a busy week for the biotech sector with quite a few FDA approvals and some strategic partnerships.
- Zacks
Gilead Partners with Scholar Rock for Fibrotic Disease Drugs
Gilead Sciences (GILD) collaborates with Scholar Rock Holding Corporation for the development of fibrotic disease candidates.
- Benzinga
Raymond James: Gilead In NASH For The Long Haul
Gilead Sciences, Inc. (NASDAQ: GILD ) announced a strategic collaboration Wednesday with Scholar Rock Holding Corp (NASDAQ: SRRK ). Although not strictly a nonalcoholic steatohepatitis, or NASH, deal, ...
